US Patent 9127059 Anti P2X7 receptor antibodies and fragments thereof
Patent 9127059 was granted and assigned to Biosceptre International Limited on September, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+186 characters)
Article
Patent abstract
The invention relates to an antigen binding site for binding to a P2X7 receptor, the antigen binding site being defined by general formula 1:FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09127059 Anti P2X7 receptor antibodies and fragments thereof US Patent 9127059 Anti P2X7 receptor antibodies and fragments thereof
Infobox
Patent Number
091270590
Patent Number
91270590
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091270590
Date of Patent
September 8, 2015
0Patent Application Number
133916190
Date Filed
August 20, 2010
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09127059 Anti P2X7 receptor antibodies and fragments thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09127059
Date of patent
September 8, 2015
Patent application number
13391619
Date Filed
August 20, 2010
Patent primary examiner
Find more entities like US Patent 9127059 Anti P2X7 receptor antibodies and fragments thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
